To explore the clinical implications of the dysregulated lncRNAs, first, we analyzed the gene expression profiling of AML collected at diagnosis, and compared the expression of FTO, LIN892, LIN989, PROX1-AS1 and SENCR among different response groups. Here, FTO is linked to acute myeloid leukemia.